Search clinical trials for: Pertuzumab
Total 454 results
-
Helsinki University Central HospitalActive, not recruiting
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Hoffmann-La RocheGenentech, Inc.CompletedBreast CancerUnited States, Italy, United Kingdom, Australia, Austria, Belgium, Brazil, Denmark, France, Guatemala, Korea, Republic of, Portugal, Spain, Turkey, Colombia, Canada, Czechia, Japan, Poland, Romania, Russian Federation, Switzerland, ... and more
-
Thomas HatschekActive, not recruitingEarly-Stage Breast Carcinoma | HER-2 Positive Breast CancerSweden
-
University Hospital HeidelbergNational Center for Tumor Diseases, HeidelbergCompletedAcute Myeloid LeukemiaGermany
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
EirGenix, Inc.Sacura GmbHCompleted
-
Kimberly BlackwellTerminatedHER2 Positive Untreated Metastatic Breast Cancer | Asymptomatic or Low Symptomatic Brain Metastasis in Breast CancerUnited States
-
University of OxfordBoehringer Ingelheim; Prostate Cancer UKActive, not recruiting
-
Shaare Zedek Medical CenterRecruiting
-
University of UlmCompleted
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
Qamar KhanRecruitingHER2-positive Breast CancerUnited States
-
Mayo ClinicRecruitingCastration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompleted
-
Vor BiopharmaRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Canada
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
The Cleveland ClinicNational Cancer Institute (NCI); University of MichiganCompletedMyelodysplastic Syndromes | LeukemiaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Seagen Inc.Merck Sharp & Dohme LLCRecruitingHER2 Positive Breast CancerUnited States, Taiwan, Canada, Korea, Republic of, Austria, China, Spain, Japan, France, Italy, Switzerland, Australia, Belgium, Brazil, Germany, Portugal, United Kingdom, Netherlands, Czechia, Greece, Chile, Finland, Poland
-
Tianjin Medical University Cancer Institute and...Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHER2+ Early or Locally Advanced Breast Cancer
-
John QuigleyPfizer; AbbVieActive, not recruiting
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdCompletedSimilarity of Pharmacokinetics and SafetyChina
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Fudan UniversityRecruiting
-
German Cancer Research CenterUniversity Hospital Heidelberg; University Hospital DresdenNot yet recruitingRelapsed/Refractory Acute Myeloid Leukemia (AML)Germany
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island HospitalActive, not recruitingAcute Myeloid LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Hoffmann-La RocheActive, not recruiting
-
Dana-Farber Cancer InstituteGenentech, Inc.Active, not recruitingBreast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingAdvanced HER2+Breast CancerBelgium, France, China, Italy, Spain, Malaysia, United States, Turkey
-
Versailles HospitalCompletedAcute Myeloid LeukemiaFrance
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Myeloid LeukemiaItaly
-
Gilead SciencesTerminatedWaldenstrom MacroglobulinemiaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's LymphomaUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Genzyme, a Sanofi CompanyTerminated
-
National Cancer Institute (NCI)TerminatedAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast CarcinomaUnited States
-
AC Camargo Cancer CenterRecruitingBreast Neoplasms | HER2-positive Breast Cancer | Circulating Tumor CellBrazil
-
Dana-Farber Cancer InstituteGenentech, Inc.; Eisai Inc.TerminatedMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
M.D. Anderson Cancer CenterCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
The Methodist Hospital Research InstituteAstraZenecaRecruitingBreast CancerUnited States
-
PfizerNo longer availableCD33 Positive Acute Myelogenous LeukemiaUnited States
-
Jules Bordet InstituteHoffmann-La Roche; Breast International Group; Institut Curie; International Drug...SuspendedHER2-positive Breast Cancer | ER-Negative Breast Cancer | PR-Negative Breast Cancer | Node-negative Breast CancerKorea, Republic of, France, Israel, Belgium, Switzerland, Australia
-
Hoffmann-La RocheActive, not recruitingSolid TumorKorea, Republic of, China, France, Portugal, Spain, Brazil, Germany, Italy, Peru, Russian Federation, Japan, Ukraine, Costa Rica, Mexico, Poland
-
Hoffmann-La RocheCompletedEarly Breast CancerFrance, Spain, United States, Korea, Republic of, Canada, United Kingdom, Argentina, Belgium, Germany, Italy, Taiwan, Thailand, Japan, Brazil, Mexico, Czechia, Poland, Russian Federation, Ukraine
-
UCB PharmaWithdrawnSystemic Lupus ErythematosusUnited States, France, United Kingdom, Spain, Belgium, Netherlands, Canada, Brazil, Germany, Hungary, Czech Republic, Italy, Slovakia